Skip to main content
Hepatitis Monthly logoLink to Hepatitis Monthly
letter
. 2015 Oct 24;15(10):e17343. doi: 10.5812/hepatmon.17343

Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures

Muhammad Sohail Afzal 1,*, Tahir Ahmad 2, Haroon Ahmed 3
PMCID: PMC4644630  PMID: 26587032

Dear Editor,

Hepatitis C virus (HCV) is the leading cause of liver related morbidity and mortality in the world; with more than 180 million infected patients (1). HCV prevalence is very low in Iran. The recent reports from Iran showed that HCV prevalence in general population was about 0.05% - 0.2% (2, 3). Due to globalization and traveling worldwide, especially to the neighboring countries, there is a chance of viral spread (4). The major factors involved in HCV spread are intravenous drug abuse, unhealthy medical practices, sharing contaminated objects such as needles and barbers' unawareness (5). Host factors are also involved in disease susceptibility, progression and viral self-clearance (6, 7). Recently, Zamani et al. (3) showed that unsterile punctures and history of infection in family members were associated with HCV spread. Despite obligatory blood screening for HCV, the prevalence of HCV infection raised dramatically in recent decades in the Middle-Eastern region. Currently, HCV prevalence in general Iranian population is very low; massive awareness campaigns should be done on a regular basis to educate general population to control the viral spread.

Footnotes

Authors’ Contributions:Study concept, design and manuscript drafting: Muhammad Sohail Afzal, Tahir Ahmad, Haroon Ahmed.

Funding/Support:The current study was supported by higher education commission of Pakistan.

References

  • 1.Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and Structural Analysis of 3' Untranslated Region of Hepatitis C Virus, Genotype 3a, From Pakistani Isolates. Hepat Mon. 2013;13(5):e17343. doi: 10.5812/hepatmon.8390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013;13(3):e17343. doi: 10.5812/hepatmon.7723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian FS, Ajdarkosh H, et al. Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: A Population-Based Study (2008-2011). Hepat Mon. 2013;13(12):e17343. doi: 10.5812/hepatmon.13313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Afzal MS, Anjum S, Zaidi NUSS. Changing of HCV Clade Pattern in Iran; the Possible Means for Something Good. Hepat Mon. 2014;14(1):e17343. doi: 10.5812/hepatmon.11879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Afzal MS, Ahmed T, Zaidi NUSS. Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future. Hepat Mon. 2014;14(1):e17343. doi: 10.5812/hepatmon.11466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011;5(6):473–9. doi: 10.3855/jidc.1338. [DOI] [PubMed] [Google Scholar]
  • 7.Afzal MS, Anjum S, Zaidi NUSS. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-α Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepat Mon. 2013;13(6):e17343. doi: 10.5812/hepatmon.10274. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Hepatitis Monthly are provided here courtesy of Brieflands

RESOURCES